Story perspectives

FDA Proposes New Sunscreen Ingredient for 2026 Approval

12/12/2025

25 2

Summary

Story summary

The U.S. Food and Drug Administration proposed adding bemotrizinol as a new active ingredient in over-the-counter sunscreens, with a final decision by mid-2026.
Bemotrizinol is already used in Europe and Asia, offering broad UVA/UVB protection with low skin absorption.
FDA Commissioner Marty Makary criticized slow sunscreen innovation, and the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) supports streamlined OTC drug approvals with public comments to be accepted.

1 of 1

Story summary

The U.S. Food and Drug Administration proposed adding bemotrizinol as a new active ingredient in over-the-counter sunscreens, with a final decision by mid-2026.
Bemotrizinol is already used in Europe and Asia, offering broad UVA/UVB protection with low skin absorption.
FDA Commissioner Marty Makary criticized slow sunscreen innovation, and the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) supports streamlined OTC drug approvals with public comments to be accepted.